Австралия - английский - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg); valsartan, quantity: 160 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: crospovidone; magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; hypromellose; purified talc; iron oxide red; macrogol 4000; titanium dioxide; iron oxide yellow - exforge hct is indicated only as substitution therapy for the treatment of hypertension in patients whose blood pressure is already adequately controlled on the triple combination of amlodipine, valsartan and hydrochlorothiazide taken either as three single component formulations or as dual-component formulation with a single component formulation, all components at the same dose level. treatment should not be initiated with these fixed-dose combinations (see dosage and administration).

Австралия - английский - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg); valsartan, quantity: 160 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; microcrystalline cellulose; crospovidone; magnesium stearate; titanium dioxide; hypromellose; purified talc; macrogol 4000 - exforge hct is indicated only as substitution therapy for the treatment of hypertension in patients whose blood pressure is already adequately controlled on the triple combination of amlodipine, valsartan and hydrochlorothiazide taken either as three single component formulations or as dual-component formulation with a single component formulation, all components at the same dose level. treatment should not be initiated with these fixed-dose combinations (see dosage and administration).

Австралия - английский - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 10 mg; valsartan, quantity: 160.001 mg - tablet - excipient ingredients: magnesium stearate; powdered cellulose; purified talc; hyprolose; iron oxide yellow; calcium hydrogen phosphate; iron oxide red; hypromellose; macrogol 8000; silicon dioxide; titanium dioxide; purified water; aluminium magnesium silicate; croscarmellose sodium - the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 10 mg; valsartan, quantity: 160.001 mg - tablet - excipient ingredients: purified talc; purified water; iron oxide yellow; croscarmellose sodium; powdered cellulose; titanium dioxide; calcium hydrogen phosphate; silicon dioxide; magnesium stearate; iron oxide red; hyprolose; aluminium magnesium silicate; macrogol 8000; hypromellose - the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 10 mg; valsartan, quantity: 160.001 mg - tablet - excipient ingredients: purified talc; iron oxide yellow; hyprolose; aluminium magnesium silicate; magnesium stearate; hypromellose; purified water; iron oxide red; powdered cellulose; titanium dioxide; calcium hydrogen phosphate; silicon dioxide; croscarmellose sodium; macrogol 8000 - the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 10 mg; valsartan, quantity: 320.001 mg - tablet - excipient ingredients: purified water; hypromellose; magnesium stearate; iron oxide yellow; macrogol 8000; powdered cellulose; silicon dioxide; aluminium magnesium silicate; purified talc; titanium dioxide; croscarmellose sodium; calcium hydrogen phosphate; hyprolose - the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 10 mg; valsartan, quantity: 320.001 mg - tablet - excipient ingredients: purified water; hyprolose; calcium hydrogen phosphate; purified talc; macrogol 8000; croscarmellose sodium; aluminium magnesium silicate; powdered cellulose; magnesium stearate; iron oxide yellow; titanium dioxide; hypromellose; silicon dioxide - the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 10 mg; valsartan, quantity: 160.001 mg - tablet - excipient ingredients: silicon dioxide; purified water; aluminium magnesium silicate; macrogol 8000; iron oxide red; hypromellose; hyprolose; magnesium stearate; powdered cellulose; iron oxide yellow; purified talc; calcium hydrogen phosphate; titanium dioxide; croscarmellose sodium - the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 10 mg; valsartan, quantity: 320.001 mg - tablet - excipient ingredients: macrogol 8000; silicon dioxide; hyprolose; purified water; iron oxide yellow; calcium hydrogen phosphate; titanium dioxide; aluminium magnesium silicate; powdered cellulose; hypromellose; purified talc; magnesium stearate; croscarmellose sodium - the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 10 mg; valsartan, quantity: 320.001 mg - tablet - excipient ingredients: powdered cellulose; titanium dioxide; croscarmellose sodium; silicon dioxide; hyprolose; purified water; purified talc; macrogol 8000; calcium hydrogen phosphate; aluminium magnesium silicate; iron oxide yellow; magnesium stearate; hypromellose - the treatment of hypertension. treatment should not be initiated with this fixed dose combination.